Literature DB >> 20523343

Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.

Fei Zhao1, Yan Chen, Ling-lan Zeng, Rui Li, Rong Zeng, Lu Wen, Yuan Liu, Chun Zhang.   

Abstract

AIM: To investigate the effects of triptolide on proliferation and apoptosis as well as on the expression of RIZ1 in the human multiple myeloma cell line U266 in vitro.
METHODS: The effect of triptolide on the growth of U266 cells was studied by MTT assay. Apoptosis was detected by Hoechst 33258 staining and Annexin V/PI double-labeled flow cytometry, and caspase-3 mRNA was measured by RT-PCR. Western blotting, flow cytometry and RT-PCR were used to assess the expression of RIZ1, and the location and expression of H3K9me1 were detected by confocal microscopy and Western blotting.
RESULTS: Triptolide significantly inhibited the proliferation of U266 cells in a time- and concentration-dependent manner (the IC(50) value for a 24-h exposure was 157.19+/-0.38 nmol/L). Triptolide induced typical apoptotic morphological changes. Triptolide 40, 80, and 160 nmol/L treatment induced significant caspase-3-dependent apoptosis compared with control group (10.5%+/-1.23%, 37.9%+/-2.45%, and 40.5%+/-2.30% vs 3.8%+/-1.98%, P<0.05). Compared with peripheral blood monocular cells (PBMC) from healthy donors, the protein expression of RIZ1 in U266 cells was relatively low, but the mRNA and protein expression of RIZ1 were strikingly increased by triptolide in a concentration-dependent manner. Triptolide increased the protein expression of RIZ1 and RIZ1 methylates histone H3 lysine 9 in U266 cells.
CONCLUSION: Triptolide increased the protein expression of RIZ1, inhibited the proliferation, and induced caspase-dependent apoptosis in U266 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523343      PMCID: PMC4002971          DOI: 10.1038/aps.2010.49

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  27 in total

1.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.

Authors:  G Steele-Perkins; W Fang; X H Yang; M Van Gele; T Carling; J Gu; I M Buyse; J A Fletcher; J Liu; R Bronson; R B Chadwick; A de la Chapelle; X Zhang; F Speleman; S Huang
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

2.  Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation.

Authors:  Patrizia Gazzerro; Ciro Abbondanza; Andrea D'Arcangelo; Mariangela Rossi; Nicola Medici; Bruno Moncharmont; Giovanni Alfredo Puca
Journal:  Exp Cell Res       Date:  2005-12-13       Impact factor: 3.905

3.  Triptolide inhibits the growth and metastasis of solid tumors.

Authors:  Shanmin Yang; Jinguo Chen; Zhen Guo; Xue-Ming Xu; Luping Wang; Xu-Fang Pei; Jing Yang; Charles B Underhill; Lurong Zhang
Journal:  Mol Cancer Ther       Date:  2003-01       Impact factor: 6.261

4.  Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.

Authors:  Taija M Kiviharju; Philip S Lecane; Robert G Sellers; Donna M Peehl
Journal:  Clin Cancer Res       Date:  2002-08       Impact factor: 12.531

5.  Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Teresa McQueen; David Harris; Zeev Estrov; Randall L Evans; Michael Andreeff
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

6.  The effect of triptolide on apoptosis of glioblastoma multiforme (GBM) cells.

Authors:  J Lin; L-Y Chen; Z-X Lin; M-L Zhao
Journal:  J Int Med Res       Date:  2007 Sep-Oct       Impact factor: 1.671

7.  Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma.

Authors:  G H Piao; W H Piao; Y He; H H Zhang; G Q Wang; Z Piao
Journal:  Histol Histopathol       Date:  2008-10       Impact factor: 2.303

8.  Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Martin F Dietrich; Clemencia Pinilla; Lyubomir T Vassilev; John C Reed; Michael Andreeff
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

Review 9.  Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.

Authors:  Constantine S Mitsiades; Nicholas S Mitsiades; Paul G Richardson; Nikhil C Munshi; Kenneth C Anderson
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

10.  Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.

Authors:  S Nomoto; T Kinoshita; K Kato; S Otani; H Kasuya; S Takeda; N Kanazumi; H Sugimoto; A Nakao
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

View more
  7 in total

1.  Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.

Authors:  Lu Wen; Yan Chen; Ling-lan Zeng; Fei Zhao; Rui Li; Yuan Liu; Chun Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

2.  LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression.

Authors:  Dong-Dong Wu; Li Huang; Lei Zhang; Le-Yu Wu; Yuan-Chao Li; Linyin Feng
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

3.  Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Authors:  Hua Gao; Fei Wang; Xiaolei Lan; Chuzhong Li; Jie Feng; Jiwei Bai; Lei Cao; Songbai Gui; Lichuan Hong; Yazhuo Zhang
Journal:  BMC Cancer       Date:  2015-04-12       Impact factor: 4.430

4.  Dual role of nanoparticles as drug carrier and drug.

Authors:  Hirak Kumar Patra; Anjan Kr Dasgupta; Sounik Sarkar; Indranil Biswas; Arnab Chattopadhyay
Journal:  Cancer Nanotechnol       Date:  2011-01-01

Review 5.  Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Authors:  Xuanbin Wang; Yibin Feng; Ning Wang; Fan Cheung; Hor Yue Tan; Sen Zhong; Charlie Li; Seiichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-10-14       Impact factor: 3.411

6.  Hif-1α Overexpression Improves Transplanted Bone Mesenchymal Stem Cells Survival in Rat MCAO Stroke Model.

Authors:  Bingke Lv; Feng Li; Jianbang Han; Jie Fang; Limin Xu; Chengmei Sun; Tian Hua; Zhongfei Zhang; Zhiming Feng; Xiaodan Jiang
Journal:  Front Mol Neurosci       Date:  2017-03-29       Impact factor: 5.639

7.  C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.

Authors:  Shu-Guang Li; Qian-Wei Shi; Ling-Yan Yuan; Li-Ping Qin; Yan Wang; Yu-Qing Miao; Zhe Chen; Chang-Quan Ling; Wen-Xing Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.